Published in Eur J Nucl Med Mol Imaging on February 01, 2004
18FDG imaging of giant cell arteritis: usefulness of whole-body plus brain PET. Eur J Nucl Med Mol Imaging (2004) 0.76
A plea for the elective inclusion of the brain in routine whole-body FDG PET. Eur J Nucl Med Mol Imaging (2005) 0.75
The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis. Arthritis Rheum (1990) 8.92
Takayasu arteritis. Ann Intern Med (1994) 5.94
Imaging of large vessel vasculitis with (18)FDG PET: illusion or reality? A critical review of the literature data. Eur J Nucl Med Mol Imaging (2003) 2.77
Increased metabolic activity in the thymus gland studied with 18F-FDG PET: age dependency and frequency after chemotherapy. J Nucl Med (2001) 1.32
Diagnosis and monitoring of central nervous system involvement in systemic lupus erythematosus: value of F-18 fluorodeoxyglucose PET. Ann Rheum Dis (2000) 1.08
Cerebrovascular findings in Takayasu disease. J Neuroimaging (2000) 0.78
Intracranial haemodynamics in Takayasu's arteritis. Acta Neurochir (Wien) (1992) 0.77
Neurosurgical and neuroendovascular management of Takayasu's arteritis. Neurosurgery (2000) 0.76
Cerebral blood flow and metabolism of steal syndrome evaluated by PET. Neurology (1999) 0.75
2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative. Arthritis Rheum (2013) 5.99
2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative. Ann Rheum Dis (2013) 3.11
Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database. Ann Rheum Dis (2010) 2.71
Predictors and prevalence of paraganglioma syndrome associated with mutations of the SDHC gene. JAMA (2005) 2.69
Effects of early corticosteroid treatment on magnetic resonance imaging and ultrasonography findings in giant cell arteritis. Rheumatology (Oxford) (2012) 2.35
Pheochromocytomas: detection with 18F DOPA whole body PET--initial results.. Radiology (2002) 1.96
18F-DOPA positron emission tomography for the detection of glomus tumours. Eur J Nucl Med Mol Imaging (2003) 1.65
Erectile dysfunction is frequent in systemic sclerosis and associated with severe disease: a study of the EULAR Scleroderma Trial and Research group. Arthritis Res Ther (2012) 1.44
Acute renal failure due to a malignant lymphoma infiltration uncovered by renal biopsy. Nephrol Dial Transplant (2004) 1.42
[Neuropsychiatric involvement in systemic lupus erythematosus. Part 2: diagnostic and therapy]. Med Klin (Munich) (2003) 1.40
Mitochondrial DNA and sperm quality in patients under antiretroviral therapy. AIDS (2003) 1.38
Time-dependent and tissue-specific accumulation of mtDNA and respiratory chain defects in chronic doxorubicin cardiomyopathy. Circulation (2003) 1.36
Immunomodulatory properties of mesenchymal stem cells: a review based on an interdisciplinary meeting held at the Kennedy Institute of Rheumatology Division, London, UK, 31 October 2005. Arthritis Res Ther (2007) 1.35
Mitochondrial toxicity of tenofovir, emtricitabine and abacavir alone and in combination with additional nucleoside reverse transcriptase inhibitors. Antivir Ther (2007) 1.26
Impact of FDG PET for staging of Ewing sarcomas and primitive neuroectodermal tumours. Nucl Med Commun (2006) 1.23
Hepatocerebral mitochondrial DNA depletion syndrome caused by deoxyguanosine kinase (DGUOK) mutations. Arch Neurol (2006) 1.22
Update on the profile of the EUSTAR cohort: an analysis of the EULAR Scleroderma Trials and Research group database. Ann Rheum Dis (2012) 1.21
Mitochondrial tubulopathy in tenofovir disoproxil fumarate-treated rats. J Acquir Immune Defic Syndr (2009) 1.21
Multiple chemical sensitivity syndrome (MCS)--suggestions for an extension of the U.S. MCS-case definition. Int J Hyg Environ Health (2005) 1.19
Thymic carcinoma with overexpression of mutated KIT and the response to imatinib. N Engl J Med (2004) 1.19
Tissue-specific mtDNA lesions and radical-associated mitochondrial dysfunction in human hearts exposed to doxorubicin. J Pathol (2005) 1.17
Ritonavir boosted indinavir treatment as a simplified maintenance "mono"-therapy for HIV infection. AIDS (2004) 1.17
Role of mitochondria in HIV lipoatrophy: insight into pathogenesis and potential therapies. Mitochondrion (2004) 1.16
Th17 cells, not IL-17+ γδ T cells, drive arthritic bone destruction in mice and humans. J Immunol (2011) 1.14
Role of mtDNA lesions in anthracycline cardiotoxicity. Cardiovasc Toxicol (2007) 1.14
PET-measured responses of MBF to cold pressor testing correlate with indices of coronary vasomotion on quantitative coronary angiography. J Nucl Med (2004) 1.13
High-dose cholecalciferol to correct vitamin D deficiency in haemodialysis patients. Nephrol Dial Transplant (2008) 1.12
Positron emission tomography-measured abnormal responses of myocardial blood flow to sympathetic stimulation are associated with the risk of developing cardiovascular events. J Am Coll Cardiol (2005) 1.12
The impact of 18F-FDG PET on the management of patients with suspected large vessel vasculitis. Eur J Nucl Med Mol Imaging (2011) 1.12
Uridine supplementation for the treatment of antiretroviral therapy-associated lipoatrophy: a randomized, double-blind, placebo-controlled trial. Antivir Ther (2007) 1.09
Enhanced neutrophil extracellular trap generation in rheumatoid arthritis: analysis of underlying signal transduction pathways and potential diagnostic utility. Arthritis Res Ther (2014) 1.07
Mitochondrial DNA and its respiratory chain products are defective in doxorubicin nephrosis. Nephrol Dial Transplant (2004) 1.04
The HIV-1 nucleoside reverse transcriptase inhibitors stavudine and zidovudine alter adipocyte functions in vitro. AIDS (2004) 1.02
Uridine supplementation antagonizes zalcitabine-induced microvesicular steatohepatitis in mice. Hepatology (2007) 0.97
Vascular involvement in patients with giant cell arteritis determined by duplex sonography of 2x11 arterial regions. Ann Rheum Dis (2010) 0.96
Increased mtDNA levels without change in mitochondrial enzymes in peripheral blood mononuclear cells of infants born to HIV-infected mothers on antiretroviral therapy. HIV Clin Trials (2008) 0.96
Assessment of precision and concordance of quantitative mitochondrial DNA assays: a collaborative international quality assurance study. J Clin Virol (2003) 0.96
Effects of of didanosine-related depletion of mtDNA in human T lymphocytes. J Infect Dis (2005) 0.95
Uridine pharmacokinetics of mitocnol, a sugar cane extract. AIDS (2005) 0.94
Comparison of dorsocervical with abdominal subcutaneous adipose tissue in patients with and without antiretroviral therapy-associated lipodystrophy. Diabetes (2011) 0.94
Renal toxicity after radionuclide therapy. Radiat Res (2004) 0.93
Factors influencing [F-18] 2-fluoro-2-deoxy-D-glucose (F-18 FDG) uptake in melanoma cells: the role of proliferation rate, viability, glucose transporter expression and hexokinase activity. J Dermatol (2005) 0.93
Assessment of adipokine expression and mitochondrial toxicity in HIV patients with lipoatrophy on stavudine- and zidovudine-containing regimens. J Acquir Immune Defic Syndr (2005) 0.93
Giant cell arteritis: diagnostic accuracy of MR imaging of superficial cranial arteries in initial diagnosis-results from a multicenter trial. Radiology (2014) 0.93
Pyrimidine nucleoside depletion sensitizes to the mitochondrial hepatotoxicity of the reverse transcriptase inhibitor stavudine. Am J Pathol (2008) 0.92
Positron emission tomography/computed tomography and whole-body magnetic resonance imaging in staging of advanced nonsmall cell lung cancer--initial results. Invest Radiol (2008) 0.92
[Ocular syphilis]. Klin Monbl Augenheilkd (2002) 0.91
MRI and (18)FDG-PET in the assessment of bone marrow infiltration of the spine in cancer patients. Eur Spine J (2007) 0.90
Involvement of the ophthalmic artery in giant cell arteritis visualized by 3T MRI. Rheumatology (Oxford) (2009) 0.89
Mitochondrial disease in the offspring as a result of antiretroviral therapy. Expert Opin Drug Saf (2006) 0.89
Radioiodine therapy in Graves' disease based on tissue-absorbed dose calculations: effect of pre-treatment thyroid volume on clinical outcome. Eur J Nucl Med Mol Imaging (2002) 0.89
Systemic sclerosis without antinuclear antibodies or Raynaud's phenomenon: a multicentre study in the prospective EULAR Scleroderma Trials and Research (EUSTAR) database. Rheumatology (Oxford) (2012) 0.88
No association between systemic sclerosis and C77G polymorphism in the human PTPRC (CD45) gene. J Rheumatol (2008) 0.87
Mitochondrial toxicity in HIV type-1-exposed pregnancies in the era of highly active antiretroviral therapy. Antivir Ther (2009) 0.86
Multisegmental spondylitis due to Tropheryma whipplei: case report. Orphanet J Rare Dis (2009) 0.86
First clinical evidence that imaging with somatostatin receptor antagonists is feasible. J Nucl Med (2011) 0.86
Uridine supplementation in the treatment of HIV lipoatrophy: results of ACTG 5229. AIDS (2010) 0.86
Methodological challenges in monitoring new treatments for rare diseases: lessons from the cryopyrin-associated periodic syndrome registry. Orphanet J Rare Dis (2013) 0.85
Long-lived plasma cells and memory B cells produce pathogenic anti-GAD65 autoantibodies in Stiff Person Syndrome. PLoS One (2010) 0.85
Hypercalcemia after transplant nephrectomy in a hemodialysis patient: a case report. J Med Case Rep (2007) 0.84
Muscle-fiber transdifferentiation in an experimental model of respiratory chain myopathy. Arthritis Res Ther (2012) 0.84
Mitochondrial toxicity of nucleoside analogues in primary human lymphocytes. Antivir Ther (2005) 0.84
Prevalence, correlates and outcomes of gastric antral vascular ectasia in systemic sclerosis: a EUSTAR case-control study. J Rheumatol (2013) 0.83
More about masitinib. Arthritis Res Ther (2009) 0.83
Coronary vasoregulation in patients with various risk factors in response to cold pressor testing: contrasting myocardial blood flow responses to short- and long-term vitamin C administration. J Am Coll Cardiol (2003) 0.83
Registries in systemic sclerosis: a worldwide experience. Rheumatology (Oxford) (2011) 0.83
Correlation of muscle BOLD MRI with transcutaneous oxygen pressure for assessing microcirculation in patients with systemic sclerosis. J Magn Reson Imaging (2013) 0.83
Analysis of blood flow and glucose metabolism in mammary carcinomas and normal breast: a H2(15)O PET and 18F-FDG PET study. Nucl Med Commun (2007) 0.82
Uridine supplementation antagonizes zidovudine-induced mitochondrial myopathy and hyperlactatemia in mice. Arthritis Rheum (2008) 0.82
Uridine excess does not interfere with the antiretroviral efficacy of nucleoside analogue reverse transcriptase inhibitors. Antivir Ther (2003) 0.82
Ulnar artery occlusion is predictive of digital ulcers in SSc: a duplex sonography study. Rheumatology (Oxford) (2011) 0.82
Beneficial effects of oral uridine in mitochondrial toxicity. AIDS (2004) 0.82
Quality assessment of human mitochondrial DNA quantification: MITONAUTS, an international multicentre survey. Mitochondrion (2011) 0.82
Is there an optimal scan time for 6-[F-18]fluoro-L-DOPA PET in pheochromocytomas and paragangliomas? Clin Nucl Med (2012) 0.81
Streptococcal hypersensitivity reloaded: severe inflammatory syndrome in Behcet's disease following 23-valent polysaccharide Streptococcus pneumoniae vaccine. Rheumatology (Oxford) (2011) 0.81
Non-invasive differentiation of pancreatic lesions: is analysis of FDG kinetics superior to semiquantitative uptake value analysis? Eur J Nucl Med Mol Imaging (2002) 0.81
The 6-maleimidocaproyl hydrazone derivative of doxorubicin (DOXO-EMCH) is superior to free doxorubicin with respect to cardiotoxicity and mitochondrial damage. Int J Cancer (2007) 0.80
Hepatic steatosis with stavudine in HIV/hepatitis C virus co-infection. AIDS (2005) 0.80
MRI in psoriatic arthritis with hand and foot involvement. Rheumatol Int (2006) 0.80
Evolution of radiographic joint damage in rituximab-treated versus TNF-treated rheumatoid arthritis cases with inadequate response to TNF antagonists. Ann Rheum Dis (2012) 0.80
Late-onset systemic sclerosis--a systematic survey of the EULAR scleroderma trials and research group database. Rheumatology (Oxford) (2010) 0.80
EUSTAR biobanking: recommendations for the collection, storage and distribution of biospecimens in scleroderma research. Ann Rheum Dis (2011) 0.80
Swiss consensus statement: Recommendations for optimising re-treatment with MabThera (rituximab) in rheumatoid arthritis. Swiss Med Wkly (2010) 0.79
Self-reported symptoms of pain and depression in primary fibromyalgia syndrome and rheumatoid arthritis. Nord J Psychiatry (2013) 0.79
Enhanced uridine bioavailability following administration of a triacetyluridine-rich nutritional supplement. PLoS One (2011) 0.79
Mitochondrial DNA depletion in rat liver induced by fosalvudine tidoxil, a novel nucleoside reverse transcriptase inhibitor prodrug. Antimicrob Agents Chemother (2009) 0.79
Oral uridine supplementation antagonizes the peripheral neuropathy and encephalopathy induced by antiretroviral nucleoside analogues. AIDS (2010) 0.79
The renal resistance index is increased in mild-to-moderate obstructive sleep apnoea and is reduced under continuous positive airway pressure. Nephrol Dial Transplant (2010) 0.79
Respiratory chain deficiency precedes the disrupted calcium homeostasis in chronic doxorubicin cardiomyopathy. Cardiovasc Pathol (2009) 0.79
Lean body mass-based standardized uptake value, derived from a predictive equation, might be misleading in PET studies. Eur J Nucl Med Mol Imaging (2003) 0.78
Limited effects of UV-A1 phototherapy in 3 patients with nephrogenic systemic fibrosis. Arch Dermatol (2008) 0.78
Correlation of skeletal muscle blood oxygenation level-dependent MRI and skin laser Doppler flowmetry in patients with systemic sclerosis. J Magn Reson Imaging (2013) 0.78
Do new biologics meet the unmet medical need in rheumatoid arthritis? Safety and efficacy of abatacept following B-cell depletion. Rheumatology (Oxford) (2010) 0.78
Soluble CD90 as a potential marker of pulmonary involvement in systemic sclerosis. Arthritis Care Res (Hoboken) (2013) 0.77
A German family with glucocorticoid-remediable aldosteronism. Nephrol Dial Transplant (2007) 0.77
Is radiation nephropathy caused by yttrium-90? Lancet (2002) 0.77
Comparison of C-11 methionine and C-11 choline for PET imaging of brain metastases: a prospective pilot study. Clin Nucl Med (2011) 0.77
Clinical significance of coexisting antitopoisomerase I and anticentromere antibodies in patients with systemic sclerosis: a EUSTAR group-based study. Clin Exp Rheumatol (2012) 0.77
Pharmacokinetics of zidovudine and lamivudine during oral uridine supplementation with NucleomaxX. J Acquir Immune Defic Syndr (2008) 0.77